We are live on ! Find out more
BFC

Blue Fin Capital Portfolio holdings

AUM $692M
1-Year Est. Return 27.29%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+27.29%
3 Year Est. Return
+125.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+590.83%
AUM
$125M
AUM Growth
+$11.3M
Cap. Flow
+$5.85M
Cap. Flow %
4.69%
Top 10 Hldgs %
31.83%
Holding
131
New
12
Increased
58
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
BKLN icon
Invesco Senior Loan ETF
BKLN
+$503K
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$356K
3
ACN icon
Accenture
ACN
+$331K
4
RGR icon
Sturm, Ruger & Co
RGR
+$266K
5
QCOM icon
Qualcomm
QCOM
+$247K

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$224K
2
SCCO icon
Southern Copper
SCCO
+$212K
3
RYN icon
Rayonier
RYN
+$206K
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$118K
5
IWV icon
iShares Russell 3000 ETF
IWV
+$98.9K

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Healthcare 11.23%
3 Financials 10.05%
4 Energy 9.77%
5 Consumer Staples 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVV icon
76
iShares Core S&P 500 ETF
IVV
$900B
$469K 0.38%
2,380
– –
NVS icon
77
Novartis
NVS
$291B
$462K 0.37%
5,697
– –
HD icon
78
Home Depot
HD
$347B
$455K 0.36%
5,620
+865
+18% +$68.2K
T icon
79
AT&T
T
$160B
$455K 0.36%
17,045
+33
+0.2% +$884
ELME
80
Elme Communities
ELME
$144M
$450K 0.36%
17,305
-450
-3% -$11.3K
ESRX
81
DELISTED
Express Scripts Holding Company
ESRX
$449K 0.36%
6,471
-150
-2% -$10.6K
PDLI
82
DELISTED
PDL BioPharma, Inc.
PDLI
$449K 0.36%
46,361
+22,805
+97% +$203K
ES icon
83
Eversource Energy
ES
$27.3B
$437K 0.35%
9,248
-200
-2% -$9.17K
GSK icon
84
GSK
GSK
$103B
$427K 0.34%
6,392
– –
C icon
85
Citigroup
C
$230B
$424K 0.34%
9,001
+300
+3% +$14.3K
QQQ icon
86
Invesco QQQ Trust
QQQ
$485B
$423K 0.34%
4,507
-38
-0.8% -$3.39K
WBA
87
DELISTED
Walgreens Boots Alliance
WBA
$408K 0.33%
5,504
+150
+3% +$10.5K
BXP icon
88
Boston Properties
BXP
$11.3B
$372K 0.3%
3,144
– –
PSX icon
89
Phillips 66
PSX
$82.5B
$371K 0.3%
4,607
-75
-2% -$6.18K
AB icon
90
AllianceBernstein
AB
$3.46B
$352K 0.28%
13,588
+5,350
+65% +$134K
BA icon
91
Boeing
BA
$187B
$349K 0.28%
2,746
-50
-2% -$6.53K
NBL
92
DELISTED
Noble Energy, Inc.
NBL
$346K 0.28%
4,471
– –
RDS.A
93
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$343K 0.27%
4,165
– –
WELL icon
94
Welltower
WELL
$167B
$336K 0.27%
5,355
– –
DOC icon
95
Healthpeak Properties
DOC
$14.9B
$335K 0.27%
8,899
– –
TXT icon
96
Textron
TXT
$15.3B
$335K 0.27%
8,753
+825
+10% +$32.3K
ACN icon
97
Accenture
ACN
$104B
$333K 0.27%
+4,125
New +$331K
SRCL
98
DELISTED
Stericycle Inc
SRCL
$300K 0.24%
2,530
-120
-5% -$13.7K
FXI icon
99
iShares China Large-Cap ETF
FXI
$4.33B
$299K 0.24%
8,075
-550
-6% -$19.9K
DIA icon
100
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.5B
$283K 0.23%
1,687
-37
-2% -$6.13K
2 3
4
5 6

Similar funds

CL
CIM LLC Albany, New York $692M AUM 22.9% 1-Year Est. Return
CPA
Capital Planning Advisors Roseville, California $692M AUM 21.81% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
SSA
South Street Advisors New York $690M AUM 39.17% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
CGIC
Continental General Insurance Company Austin, Texas $693M AUM 90.58% 1-Year Est. Return
LCP
Larch Capital Partners Miami, Florida $690M AUM
SAM
Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return

Blue Fin Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Blue Fin Capital held 131 positions worth $125M, up 9.9% from $113M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Blue Fin Capital deployed $5.85M of net new capital in Q2 2014, opening 12 new positions and adding to 58 existing holdings. Its largest new stake was Accenture: 4,125 shares worth $333K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rayonier, an estimated $206K trimmed.

  • Blue Fin Capital's largest Q2 2014 buy was Accenture: 4,125 shares worth $333K.
  • Blue Fin Capital added most to Invesco Senior Loan ETF in Q2 2014, an estimated $503K increase.
  • Blue Fin Capital's biggest Q2 2014 reduction was Rayonier, cutting an estimated $206K.
  • Blue Fin Capital fully exited Boston Scientific in Q2 2014, selling an estimated $224K.
  • Blue Fin Capital's ten largest holdings make up 32% of its $125M portfolio in Q2 2014.
  • Blue Fin Capital opened 12 new positions and closed 2 in Q2 2014.
  • Blue Fin Capital's portfolio value rose 9.9% quarter-over-quarter to $125M.

Based on Blue Fin Capital's 13F filing for Q2 2014, filed 29 Jul 2014.